newsfilter
← Latest News
GlobeNewswire·

Boundless Bio to Participate in the Leerink Global Healthcare Conference

SAN DIEGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with